CorMedix Inc. Announces CMS Grants TDAPA to DefenCath
April 19, 2024 08:30 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., April 19, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for...
CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath® (Taurolidine and Heparin)
April 15, 2024 08:30 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., April 15, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for...
CorMedix Inc. Announces Abstracts at Upcoming Society for Healthcare Epidemiology of America Conference
April 11, 2024 08:30 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., April 11, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing therapeutic products for life-threatening diseases and...
CorMedix Inc. Announces Commercial Agreement With ARC Dialysis, LLC
April 08, 2024 08:30 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., April 08, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing therapeutic products for life-threatening diseases and...
CorMedix Inc. to Present at the Needham Annual Healthcare Conference
March 27, 2024 08:30 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., March 27, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention...
CorMedix Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
March 12, 2024 07:30 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., March 12, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the...
CorMedix Inc. to Report Fourth Quarter and Full Year 2023 Financial Results and Provide a Corporate Update on March 12, 2024
March 06, 2024 08:30 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., March 06, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention...
CorMedix Inc. Announces Commercial and Reimbursement Updates
January 30, 2024 08:30 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., Jan. 30, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention...
CorMedix Inc. Announces Commercial and Operational Updates
January 08, 2024 08:30 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., Jan. 08, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention...
CorMedix Inc. Announces Appointment of Chief Legal Officer
December 15, 2023 08:30 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., Dec. 15, 2023 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention...